Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High vs Standard Dose Cytarabine in AML (AML-01.10)
NCT01587430Phase 4Unknown
- Sponsor
- National Medical Research Center for Hematology
- Start
- Jan 2010
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cytarabine in acute myeloid leukemia (AML), sponsored by National Medical Research Center for Hematology. Status: unknown.
02
Drugs
cytarabine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT01587430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01587430.